The stock market isn’t always a rational barometer of a company’s worth, but neither is a spreadsheet whipped up by some branding consultancy. If you find yourself …
Analysts are weighing in on how Exelixis, Inc. (NASDAQ:EXEL) , might perform in the near term. Wall Street analysts have a much favorable assessment of the stock, with a mean rating of 1.6. The stock is rated as buy by 0 analysts, …
ILLEGAL ACTIVITY NOTICE: "Exelixis, Inc". More recent Exelixis, Inc. The stock has actually made strong gains in the past year, as the company has gathered a 155.1% return in the past twelve months. The other 6, though not evenly; …
Higher the score, better the strength of the company and confidence it its operation. Version 8 of the freefincal stock analyzer computes the Piotroski Score using 10-year financials from Morning Star India. Thus the score is obtained for …
Its stock price soared as high as $46 and its workforce swelled to more than 700. But after disclosing a failed late-stage prostate cancer drug trial Monday, the South San Francisco company's (NASDAQ: EXEL) stock closed Tuesday just a …
21 AM Exelixis (EXEL) PT Bumped to $8 at Piper Jaffray, Remains Sidelined Aug 3, 2016 06:52 PM After-Hours Stock Movers 08/03: (SQ) (PODD) (JACK) Higher; (TDOC) (SGMO) (FRSH) Lower (more...) Aug 3, 2016 04:43 PM Exelixis
Looking back to 3 days ago, Exelixis Inc (NASD: EXEL) priced a 25,000,000 share secondary stock offering at $5.40 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would …
It has a 50-day SMA of $21.76 and a 200-day SMA of $18.79. For a complete fundamental analysis analysis of Exelixis Inc., check out Equities.com’s Stock Valuation Analysis report for EXEL. Exelixis Inc is a part of the healthcare sector. …
From the opening price, the stock has seen a change of -1.37% recently clocking in with a price of $23.78. The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers …
Exelixis, Inc. (EXEL) retreated -3.11% to reach at the floor price of $4.67 as the company is set to share its latest quarterly earnings after to closing bell on May 04, 2016. EXEL stock trades between $4.63 and $4.78 before the earnings release.